The treatment of portal hypertension: A meta‐analytic review

[1]  P. Arcidiacono,et al.  Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study , 1988 .

[2]  E. Fesce,et al.  Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: A prospective, randomized study , 1988, Hepatology.

[3]  Paquet Kj.  Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices -- a prospective controlled randomized trial. , 1982 .

[4]  G. D’Amico,et al.  Six-Week Prognostic Indicators in Upper Gastro-Intestinal Haemorrhage in Cirrhosis , 1986 .

[5]  P. Arcidiacono,et al.  Prophylactic sclerotherapy in high-risk cirrhotics selected by endoscopic criteria , 1991 .

[6]  S. Dasarathy,et al.  A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy. , 1993, Journal of hepatology.

[7]  Mort H Glickman,et al.  Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension , 1982, Hepatology.

[8]  J. Bruix,et al.  Comparison of Intravenous Somatostatin and Vasopressin Infusions in Treatment of Acute Variceal Hemorrhage , 1984, Hepatology.

[9]  Rector Wg,et al.  Risk factors for haemorrhage from oesophageal varices and acute gastric erosions. , 1985 .

[10]  R. Groszmann,et al.  Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. , 1990, Gastroenterology.

[11]  B. Katzen,et al.  Percutaneous transjugular portosystemic shunt. , 1991, JAMA.

[12]  R. Groszmann,et al.  Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal hemorrhage: A placebo‐controlled clinical trial , 1989, Hepatology.

[13]  G. Krejs,et al.  Prophylactic sclerotherapy of large esophageal varices. , 1988, The New England journal of medicine.

[14]  T. Schubert,et al.  A multicenter, randomized, double‐blind trial of somatostatin in the management of acute hemorrhage from esophageal varices , 1989, Hepatology.

[15]  J. Vinel,et al.  Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration. , 1992, Gastroenterology.

[16]  M. Kaplan.  Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients: A randomized multicenter trial , 1991 .

[17]  M. Alves,et al.  Propranolol or endoscopic sclerotherapy in the prevention of recurrence of variceal bleeding. A prospective, randomized controlled trial. , 1988, Journal of hepatology.

[18]  M. Kutner,et al.  Distal spleno-renal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. A meta-analysis of 4 randomized clinical trials. , 1992, Journal of hepatology.

[19]  P. Ducrotte,et al.  [Controlled study of propranolol in the prevention of recurrent hemorrhage in cirrhotic patients]. , 1987, Gastroenterologie clinique et biologique.

[20]  S. Lowenstein,et al.  Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophagal varices , 1992 .

[21]  J. Palmaz,et al.  Expandable intrahepatic portacaval shunt stents: early experience in the dog. , 1985, AJR. American journal of roentgenology.

[22]  H. Kreichgauer,et al.  Terlipressin vs. Somatostatin in bleeding esophageal varices: A controlled, double‐blind study , 1992, Hepatology.

[23]  M. Colombo,et al.  β‐blockade prevents recurrent gastrointestinal bleeding in well‐compensated patients with alcoholic cirrhosis: A multicenter randomized controlled trial , 1989 .

[24]  John Wright,et al.  FAILURE OF REPEATED INJECTION SCLEROTHERAPY TO IMPROVE LONG-TERM SURVIVAL AFTER OESOPHAGEAL VARICEAL BLEEDING A Five-year Prospective Controlled Clinical Trial , 1983, The Lancet.

[25]  R. Nilius,et al.  Prophylactic Endoscopic Sclerotherapy of Esophageal Varices - A Prospective Randomized Trial , 1990, Endoscopy.

[26]  K. Inokuchi.  Improved survival after prophylactic portal nondecompression surgery for esophageal varices: A randomized clinical trial , 1990, Hepatology.

[27]  J. Correia,et al.  Controlled Trial of Vasopressin and Balloon Tamponade in Bleeding Esophageal Varices , 1984, Hepatology.

[28]  D. Burnett,et al.  Shunt surgery versus endoscopic sclerotherapy for long-term treatment of variceal bleeding. Early results of a randomized trial. , 1987, Annals of surgery.

[29]  F. Santolaria,et al.  A randomized trial of somatostatin (S) versus vasopresin plus nitroglycerin (V/N) in the treatment of acute variceal bleeding (AVB) , 1991 .

[30]  A. Blei,et al.  Vasopressin analogs and portal hypertension , 1987 .

[31]  G. Grassini,et al.  Effect of somatostatin in controlling bleeding from esophageal varices. , 1987, The Italian journal of surgical sciences.

[32]  R. Shields,et al.  A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices. , 1992, Journal of hepatology.

[33]  G. D’Amico,et al.  Predictive value of ultrasonography in the screening of non‐ascitic cirrhotic patients with large varices. , 1986, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[34]  D. Stein,et al.  Continuous intravenous vasopressin in active upper gastrointestinal bleeding. , 1982, Annals of internal medicine.

[35]  A. Gimson,et al.  A controlled trial of oral propranolol compared with injection sclerotherapy for the long‐term magnagement of variceal bleeding , 1990, Hepatology.

[36]  J. Villeneuve,et al.  Systemic and hepatic hemodynamics after variceal hemorrhage: effects of propranolol and placebo. , 1987, Gastroenterology.

[37]  J. Goff,et al.  Assessment of the risk of bleeding from esophageal varices by continuous monitoring of portal pressure. , 1991, Gastroenterology.

[38]  P. Pizcueta,et al.  Enhancement of portal pressure reduction by the association of isosorbide‐5‐mononitrate to propranolol administration in patients with cirrhosis , 1990, Hepatology.

[39]  M. Pääkkönen,et al.  Comparison of somatostatin and vasopressin in bleeding esophageal varices. , 1990, The American journal of gastroenterology.

[40]  O. Garden,et al.  Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients. A controlled trial. , 1990, Gastroenterology.

[41]  R. Groszmann,et al.  Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial , 1991, Hepatology.

[42]  Alan G. Johnson,et al.  Prophylactic sclerotherapy for esophageal varices: Long‐term results of a single‐center trial , 1991, Hepatology.

[43]  N. Mcintyre,et al.  A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices. , 1989, The New England journal of medicine.

[44]  H. Conn,et al.  PROPHYLACTIC PORTACAVAL ANASTOMOSIS IN CIRRHOTIC PATIENTS WITH ESOPHAGEAL VARICES: A PROGRESS REPORT OF A CONTINUING STUDY. , 1965, The New England journal of medicine.

[45]  D. Chapman,et al.  Acute esophageal variceal sclerotherapy. Results of a prospective randomized controlled trial. , 1986, JAMA.

[46]  J. Cohen,et al.  Selective intra-arterial vasopression in fusion for upper gastrointestinal tract hemorrhage: a controlled trial. , 1980, Archives of surgery.

[47]  J. Villeneuve,et al.  Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient. , 1975, Gastroenterology.

[48]  F. Reichle,et al.  Prospective comparative clinical trial with distal splenorenal and mesocaval shunts. , 1979, American journal of surgery.

[49]  J. Visa,et al.  Randomized trial of portacaval shunt, stapling transection and endoscopic sclerotherapy in uncontrolled variceal bleeding. , 1987, Journal of hepatology.

[50]  L. Hoenig.  Ben Achiya: the first gastroenterologist in ancient Israel? , 1989, Journal of clinical gastroenterology.

[51]  A. Blei.  Vasopressin analogs in portal hypertension: Different molecules but similar questions , 1986, Hepatology.

[52]  E. Christensen,et al.  Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone. , 1981, Gastroenterology.

[53]  A. Laupacis,et al.  A meta-analysis of prophylactic endoscopic sclerotherapy for esophageal varices. , 1994, The American journal of gastroenterology.

[54]  B. Kommerell,et al.  Terlipressin in bleeding esophageal varices: A placebo‐controlled, double‐blind study , 1986, Hepatology.

[55]  Shou-Dong Lee,et al.  A Randomized Controlled Study of Triglycyl-Vasopressin and Vasopressin Plus Nitroglycerin in the Control of Acute Esophageal Variceal Hemorrhage , 1988 .

[56]  G. Fourtanier,et al.  [Treatment of bleeding oesophageal varices in cirrhotic patients with pitressin. A controlled study (author's transl)]. , 1978, Acta gastro-enterologica Belgica.

[57]  H. Feußner,et al.  Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: A prospective controlled randomized trial , 1985, Hepatology.

[58]  G. Bedogni,et al.  Nadolol for prevention of variceal rebleeding during the course of endoscopic injection sclerotherapy: a randomized pilot study. , 1990, Journal of Clinical Gastroenterology.

[59]  S. Raptis,et al.  Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial. , 1993, Journal of hepatology.

[60]  M. S. Barsoum,et al.  Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices , 1982, The British journal of surgery.

[61]  D. Sautereau,et al.  A randomized trial of terlipressin plus nitroglycerin vs. balloon tamponade in the control of acute variceal hemorrhage , 1990, Hepatology.

[62]  O. Garden,et al.  Prediction of outcome following acute variceal haemorrhage , 1985, The British journal of surgery.

[63]  P. Devitt,et al.  A prospective randomised controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal haemorrhage. , 1985, British medical journal.

[64]  R. Santambrogio,et al.  Distal splenorenal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. First stage of a randomized, controlled trial. , 1990, Annals of surgery.

[65]  M. Navasa,et al.  Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension. , 1990, Journal of hepatology.

[66]  J. Villeneuve,et al.  Propranolol for the prevention of recurrent variceal hemorrhage: A controlled trial , 1986, Hepatology.

[67]  M. Navasa,et al.  Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function. , 1989, Gastroenterology.

[68]  H. Bradby,et al.  Prevention of rebleeding from oesophageal varices: two-year follow up of a prospective controlled trial of propranolol in addition to sclerotherapy. , 1994, Journal of hepatology.

[69]  C. Record,et al.  CONTROLLED TRIAL OF TERLIPRESSIN ('GLYPRESSIN') VERSUS VASOPRESSIN IN THE EARLY TREATMENT OF OESOPHAGEAL VARICES , 1982, The Lancet.

[70]  D. Graham,et al.  The course of patients after variceal hemorrhage , 1981 .

[71]  R. Peto,et al.  Overview of randomised trials of diuretics in pregnancy. , 1985, British medical journal.

[72]  E. Cabré,et al.  Portacaval shunt versus endoscopic sclerotherapy in the elective treatment of variceal hemorrhage. , 1991, Gastroenterology.

[73]  G. Ramsby,et al.  Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: a prospective, controlled clinical trial. , 1975, Gastroenterology.

[74]  T. Chalmers,et al.  A controlled study of the prophylactic portacaval shunt. A final report. , 1969, Annals of Internal Medicine.

[75]  J. Vinel,et al.  Hemodynamic evaluation of molsidomine: A vasodilator with antianginal properties in patients with alcoholic cirrhosis , 1990, Hepatology.

[76]  N. Soehendra,et al.  Prophylactic sclerosing of esophageal varices--results of a prospective controlled study. , 1986, Endoscopy.

[77]  L. Lundell,et al.  Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions. , 1990, Acta chirurgica Scandinavica.

[78]  R. Groszmann,et al.  Portal pressure, presence of gastroesophageal varices and variceal bleeding , 1985, Hepatology.

[79]  S. D. Lee,et al.  A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding. , 1992, Journal of hepatology.

[80]  E B Rypins,et al.  A Systematic Appraisal of Portacaval H‐Graft Diameters: Clinical and Hemodynamic Perspectives , 1986, Annals of surgery.

[81]  M. L. de la Mata,et al.  Somatostatin versus Sengstaken balloon tamponade for primary haemostasia of bleeding esophageal varices. A randomized pilot study. , 1991, Journal of hepatology.

[82]  M. Gassull,et al.  Prophylactic sclerosis of esophageal varices (EV). Prospective trial , 1989 .

[83]  J. Bosch,et al.  Oral administration of clonidine in patients with alcoholic cirrhosis. Hemodynamic and liver function effects. , 1992, Gastroenterology.

[84]  E. Ancona,et al.  Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. , 1988, The New England journal of medicine.

[85]  R. Groszmann,et al.  Distal splenorenal vs. portal‐systemic shunts after hemorrhage from varices: A randomized controlled trial , 1988, Hepatology.

[86]  J. W. Griffin,et al.  Complications of endoscopic injection sclerotherapy: a review. , 1987, The American journal of gastroenterology.

[87]  J. Rodés,et al.  Propranolol versus sclerotherapy in preventing variceal rebleeding: a randomized controlled trial. , 1993, Gastroenterology.

[88]  Copenhagen Esophageal Varices Sclerotherapy.  Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial. , 1984, The New England journal of medicine.

[89]  E. Ring,et al.  Using Transjugular Intrahepatic Portosystemic Shunts to Control Variceal Bleeding before Liver Transplantation , 1992, Annals of Internal Medicine.

[90]  J. Fermanian,et al.  Gastroesophageal endoscopic features in cirrhosis. Observer variability, interassociations, and relationship to hepatic dysfunction. , 1990, Gastroenterology.

[91]  C. S. Davidson,et al.  Effect of intravenously administered posterior pituitary extract on hemorrhage from bleeding esophageal varices. A controlled evaluation. , 1962, The New England journal of medicine.

[92]  M. Kutner,et al.  The Emory Prospective Randomized Trial: Selective Versus Nonselective Shunt to Control Variceal Bleeding Ten‐year Follow‐up , 1985, Annals of surgery.

[93]  A. J. Donovan,et al.  Results of a 12-year randomized trial of portacaval shunt in patients with alcoholic liver disease and bleeding varices. , 1981, Gastroenterology.

[94]  J. Degos,et al.  A CONTROLLED STUDY OF THERAPEUTIC PORTACAVAL SHUNT IN ALCOHOLIC CIRRHOSIS , 1976, The Lancet.

[95]  C. Record,et al.  Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding. , 1989, Journal of clinical gastroenterology.

[96]  J. Fischer,et al.  Comparison of Distal and Proximal Splenorenal Shunts: A Randomized Prospective Trial , 1981, Annals of surgery.

[97]  Maria Di Giovanni,et al.  Reliability of endoscopy in the assessment of variceal features: The Italian Liver Cirrhosis Project , 1987 .

[98]  L. Capocaccia,et al.  Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis. , 1993, Gastroenterology.

[99]  A. el-Zayadi,et al.  Endoscopic sclerotherapy versus medical treatment for bleeding esophageal varices in patients with schistosomal liver disease. , 1988, Gastrointestinal endoscopy.

[100]  G. Ramsby,et al.  PROPHYLACTIC PORTACAVAL ANASTOMOSIS: A Tale of Two Studies , 1972 .

[101]  L. Blendis,et al.  Further report of a prospective randomized trial comparing distal splenorenal shunt with end-to-side portacaval shunt. An analysis of encephalopathy, survival, and quality of life. , 1985, Gastroenterology.

[102]  A Morabito,et al.  Prevention of First Bleeding in Cirrhosis , 1992, Annals of Internal Medicine.

[103]  K. Kopecky,et al.  Comparison of three nonsurgical treatments for bleeding esophageal varices. , 1989, Gastroenterology.

[104]  J. Rodés,et al.  Vasopressin/nitroglycerin infusion vs. esophageal tamponade in the treatment of acute variceal bleeding: A randomized controlled trial , 1990, Hepatology.

[105]  L. Baker,et al.  The natural history of esophageal varices; a study of 115 cirrhotic patients in whom varices were diagnosed prior to bleeding. , 1959, The American journal of medicine.

[106]  W. R. Felix,et al.  A clinical investigation of the portacaval shunt. V. Survival analysis of the therapeutic operation. , 1971, Annals of surgery.

[107]  A. Gangl,et al.  Prophylactic endoscopic sclerotherapy of oesophageal varices in liver cirrhosis. A multicentre prospective controlled randomised trial in Vienna. , 1989, Gut.

[108]  P. Angeli,et al.  Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. , 1992, Gastroenterology.

[109]  J. Canet,et al.  A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding , 1994, Hepatology.

[110]  W. Schönborn,et al.  Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: Prospective, randomized comparison of propranolol and sclerotherapy , 1987, Hepatology.

[111]  P. Angeli,et al.  Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial. , 1987, Digestion.

[112]  K. Lyons,et al.  Serial measurement of portal hemodynamics after partial portal decompression. , 1986, Surgery.

[113]  Dedeurwaerder Rj.  Therapy of liver disease. , 1950, Bailliere's clinical gastroenterology.

[114]  L. Baker,et al.  Esophageal transection versus injection sclerotherapy in the management of bleeding esophageal varices in patients at high risk. , 1985, Surgery, gynecology & obstetrics.

[115]  Roger M. Williams,et al.  Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration , 1986, Hepatology.

[116]  M. Hughes,et al.  Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. , 1990, Gastroenterology.

[117]  G. D’Amico,et al.  Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis. A randomized clinical trial. Liver Study Group of V. Cervello Hospital. , 1994, Journal of hepatology.

[118]  F. Chan,et al.  Octreotide infusion or emergency sclerotherapy for variceal haemorrhage , 1993, The Lancet.

[119]  D. Trunkey,et al.  Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and acute variceal hemorrhage. Long-term follow-up. , 1987, The New England journal of medicine.

[120]  I. J. Sarfeh,et al.  Partial Versus Total Portacaval Shunt in Alcoholic Cirrhosis Results of a Prospective, Randomized Clinical Trial , 1994, Annals of surgery.

[121]  G. Organe.  Decamethonium iodide (bistrimethyl-ammonium decane diiodide) in anaesthesia. , 1949, Lancet.

[122]  A. Burroughs,et al.  Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. , 1983, The New England journal of medicine.

[123]  B. Langer,et al.  Further report of a prospective randomized trial comparing distal splenorenal shunt with end-to-side portacaval shunt , 1985 .

[124]  L. Le Bodic,et al.  [Prevention of recurrent hemorrhage in patients with cirrhosis. Results of a controlled trial of propranolol versus endoscopic sclerotherapy]. , 1991, Gastroenterologie clinique et biologique.

[125]  P. Arcidiacono,et al.  Prophylactic sclerotherapy in high-risk cirrhotics selected by endoscopic criteria. A multicenter randomized controlled trial. , 1991, Gastroenterology.

[126]  J. Ansell,et al.  Control of Bleeding Varices by Vasopressin: A Prospective Randomized Study , 1977, Annals of surgery.

[127]  M. Zaballa,et al.  A randomized trial of tamponade or sclerotherapy as immediate treatment for bleeding esophageal varices. , 1988, Surgery, gynecology & obstetrics.

[128]  J. Bruix,et al.  Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage. , 1989, Gastroenterology.

[129]  A. Gimson,et al.  Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices , 1993, The Lancet.

[130]  T. Starzl,et al.  Liver transplantation in the management of bleeding oesophageal varices. , 1992, Bailliere's clinical gastroenterology.

[131]  P. Calès,et al.  Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. , 1987, The New England journal of medicine.

[132]  L. Balart,et al.  A prospective, randomized controlled trial of chronic esophageal variceal sclerotherapy , 1985, Hepatology.

[133]  J. Fischer,et al.  Comparison of Distal and Proximal Splenorenal Shunts , 1981 .

[134]  Roger M. Williams,et al.  Improved survival following injection sclerotherapy for esophageal varices: Final analysis of a controlled trial , 1985, Hepatology.

[135]  L. Cipolletta,et al.  Prophylactic sclerotherapy of high‐risk esophageal varices: Results of a multicentric prospective controlled trial , 1988, Hepatology.

[136]  R. Groszmann,et al.  Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. , 1992, Journal of hepatology.

[137]  H. El-Newihi,et al.  Endoscopic Ligation Compared with Sclerotherapy for the Treatment of Bleeding Esophageal Varices , 1993, Annals of Internal Medicine.

[138]  T. Sauerbruch,et al.  Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients with cirrhosis. , 1988, The New England journal of medicine.

[139]  J. Saunders,et al.  A 20-year prospective study of cirrhosis. , 1981, British medical journal.

[140]  J. Bruix,et al.  Effects of Propranolol on Azygos Venous Blood Flow and Hepatic and Systemic Hemodynamics in Cirrhosis , 1984, Hepatology.

[141]  E. Ring,et al.  Transjugular intrahepatic portosystemic shunts: preliminary results in 25 patients. , 1992, Journal of vascular surgery.

[142]  S. Kitano,et al.  Prediction of variceal hemorrhage by esophageal endoscopy. , 1981, Gastrointestinal endoscopy.

[143]  J. Vinel,et al.  Assessment of short‐term prognosis after variceal bleeding in patients with alcoholic cirrhosis by early measurement of portohepatic gradient , 1986, Hepatology.

[144]  P. Hayes,et al.  Sucralfate for the prevention of early rebleeding following injection sclerotherapy for esophageal varices , 1989 .

[145]  L. Grande,et al.  Sclerotherapy vs. Distal splenorenal shunt in the elective treatment of variceal hemorrhage: A randomized controlled trial , 1987, Hepatology.

[146]  G. Stiegmann.  Endoscopic ligation of esophageal varices. , 1988, Bildgebung = Imaging.

[147]  J. Benhamou,et al.  Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis , 1980 .

[148]  M. Korman,et al.  An 8-year prospective experience with balloon tamponade in emergency control of bleeding esophageal varices , 1982, Digestive diseases and sciences.

[149]  A. Ravaud,et al.  Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding. , 1990, Gut.

[150]  T. Poynard,et al.  Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. , 1991, The New England journal of medicine.

[151]  P. Hartigan.  Sclerotherapy for male alcoholic cirrhotic patients who have bled from esophageal varices: Results of a randomized, multicenter clinical trial , 1994, Hepatology.

[152]  L. Lundell,et al.  Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial. , 1990, Scandinavian journal of gastroenterology.

[153]  T. Poynard,et al.  Does elective sclerotherapy improve the efficacy of long‐term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trial , 1992, Hepatology.

[154]  D. Sautereau,et al.  Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: A multicenter randomized trial , 1993, Hepatology.

[155]  S. Passaretti,et al.  Comparison of somatostatin and cimetidine in the treatment of acute bleeding esophageal varices , 1986 .

[156]  M. Kutner,et al.  Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective, randomized trial. , 1990, Annals of internal medicine.

[157]  G. D’Amico,et al.  Natural history of cirrhosis , 1991 .

[158]  M. Hughes,et al.  Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding , 1990 .

[159]  Y. Liaw,et al.  A controlled study of glypressin versus vasopressin in the control of bleeding from oesophageal varices , 1990, Journal of gastroenterology and hepatology.

[160]  S. Raptis,et al.  A prospective randomized trial comparing somatostatin, balloon tamponade and the combination of both methods in the management of acute variceal haemorrhage. , 1991, Journal of hepatology.

[161]  A. Gimson,et al.  A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage , 1986, Hepatology.

[162]  F. Villamil,et al.  Results of a randomized trial of end-to-side portacaval shunt and distal splenorenal shunt in alcoholic liver disease and variceal bleeding. , 1986, Gastroenterology.

[163]  J. Dooley,et al.  Self-expandable stainless steel braided endoprosthesis for biliary strictures. , 1990, Radiology.

[164]  J. Rodés,et al.  Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study. , 1991, Annals of internal medicine.

[165]  I. Cobden,et al.  初期食道静脈りゅう治療におけるテルイプレシン(グリプレシン)とバソプレシンの比較試験 , 1982 .

[166]  S. D. Lee,et al.  Controlled trial of vasopressin plus nitroglycerin vs. vasopressin alone in the treatment of bleeding esophageal varices , 1986, Hepatology.

[167]  R. Poupon,et al.  A Randomized Controlled Study of Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with Cirrhosis: A Final Report , 1984, Hepatology.

[168]  F. T. de Dombal,et al.  Prognostic factors in upper G.I. bleeding. , 1986, Endoscopy.

[169]  J. Bosch,et al.  Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: Comparison with vasopressin , 1981 .

[170]  E. Perrin,et al.  A clinical investigation of the portacaval shunt. II. Survival analysis of the prophylactic operation. , 1968, American journal of surgery.

[171]  A. G. Oliveira,et al.  Is sclerotherapy the first choice treatment for active oesophageal variceal bleeding in cirrhotic patients? Final report of a randomized controlled trial , 1990 .

[172]  D. Bhargava,et al.  A prospective randomized trial comparing repeated endoscopic sclerotherapy and propranolol in decompensated (child class B and C) cirrhotic patients , 1992, Hepatology.

[173]  Roger M. Williams,et al.  Controlled clinical trial of injection sclerotherapy for active variceal bleeding , 1989, Hepatology.

[174]  T. Chalmers,et al.  A controlled study of the therapeutic portacaval shunt. , 1974, Gastroenterology.

[175]  B. Balkau,et al.  Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: Results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo , 1990, Hepatology.

[176]  N. Krarup,et al.  Propranolol in prevention of rebleeding from oesophageal varices during the course of endoscopic sclerotherapy. , 1989, Scandinavian journal of gastroenterology.

[177]  G. Haddock,et al.  Esophageal tamponade in the management of acute variceal hemorrhage , 1989, Digestive diseases and sciences.

[178]  M. Biraghi,et al.  Terlypressin and endoscopic sclerotherapy control variceal bleeding and prevent early rebleeding in cirrhotic patients , 1993 .

[179]  M. Bigard,et al.  [Endoscopic sclerotherapy versus propranolol after hemorrhage caused by rupture of esophageal varices in patients with cirrhosis. Results of a 4-year randomized study]. , 1988, Gastroenterologie clinique et biologique.

[180]  M. Orloff,et al.  Medical and surgical problems of portal hypertension , 1980 .

[181]  J. Rodés,et al.  Effects of molsidomine, a long acting venous dilator, on portal hypertension. A hemodynamic study in patients with cirrhosis. , 1991, Journal of hepatology.

[182]  Ak Burroughs,et al.  Methodology and reviews of clinical trials in portal hypertension , 1987 .

[183]  L. Witzel,et al.  PROPHYLACTIC ENDOSCOPIC SCLEROTHERAPY OF OESOPHAGEAL VARICES A Prospective Controlled Study , 1985, The Lancet.

[184]  Y. Liaw,et al.  Randomized controlled study of propranolol for prevention of recurrent esophageal varices bleeding in patients with cirrhosis. , 2008, Liver.

[185]  R. Williams,et al.  Injection sclerotherapy for oesophageal varices: a prospective randomised trial of different treatment schedules. , 1984, Gut.

[186]  D. Trunkey,et al.  Endoscopic sclerotherapy versus esophageal transection of Child's class C patients with variceal hemorrhage. Comparison with results of portacaval shunt: preliminary report. , 1982, Surgery.

[187]  R. Groszmann,et al.  A controlled comparison of continuous intraarterial and intravenous infusions of vasopressin in hemorrhage from esophageal varices , 1979 .

[188]  J. Reichen.  Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension , 1990, Hepatology.

[189]  J. Boissel,et al.  Considerations for the meta-analysis of randomized clinical trials. Summary of a panel discussion. , 1989, Controlled clinical trials.

[190]  V. Rossi,et al.  Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy. , 1991, Journal of hepatology.

[191]  D. Roulot,et al.  Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial. , 1988, Journal of hepatology.

[192]  A. Cirelli,et al.  Cryptococcus neoformans infection in patients with acquired immunodeficiency syndrome: Clinical forms and therapeutic possibilities , 1993 .

[193]  R. M. Conroy,et al.  Predictability and Maintenance of Portal Flow Patterns After Small‐Diameter Portacaval H‐Grafts in Man , 1984, Annals of surgery.

[194]  R. McKee,et al.  A study of octreotide in oesophageal varices. , 1990, Digestion.

[195]  R. Groszmann,et al.  Hemodynamic Factors Involved in the Development and Rupture of Esophageal Varices: A Pathophysiologic Approach to Treatment , 1986, Seminars in liver disease.

[196]  N. Mcintyre,et al.  PROSPECTIVE RANDOMIZED TRIAL OF LONG-TERM SCLEROTHERAPY FOR VARICEAL REBLEEDING USING THE SAME PROTOCOL TO TREAT REBLEEDING IN ALL PATIENTS - FINAL REPORT , 1989 .

[197]  M. Kutner,et al.  Selective shunt in the management of variceal bleeding in the era of liver transplantation. , 1992, Annals of surgery.

[198]  D. Westaby.  Emergency and elective endoscopic therapy for variceal haemorrhage. , 1992, Bailliere's clinical gastroenterology.